Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Approvals
China Biologic Products Awarded CFDA Approval To Manufacture Plasma Product 10/20/2014 10:58:37 AM
Pfizer (PFE) Release: FDA Approves Abuse Deterrent Labeling For EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended-Release (ER) Capsules CII 10/20/2014 9:33:19 AM
Halozyme Therapeutics, Inc. (HALO) Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant 10/20/2014 9:03:50 AM
Boehringer Ingelheim Corporation Wins FDA Approval For Lung Disease Drug Ofev 10/15/2014 3:14:19 PM
InterMune, Inc. (ITMN) Wins FDA Approval For Lung Drug At Center Of Roche (RHHBY) Deal 10/15/2014 3:16:10 PM
FDA Approves Expanded Use Of Navidea Biopharmaceuticals (NAVB)’s Lymphoseek® For Lymphatic Mapping In Solid Tumors 10/15/2014 10:59:40 AM
FDA Approves Gilead Sciences, Inc. (GILD)'s New Hepatitis C Drug Harvoni 10/10/2014 4:19:34 PM
ViiV Healthcare Receives Approval For Triumeq™ (dolutegravir/abacavir/lamivudine), In Canada - A New Once-Daily Single-Pill Regimen For The Treatment Of HIV 10/14/2014 2:14:21 PM
Eisai Inc. (ESALF.PK) Grabs FDA Approval For Chemotherapy Side Effect Drug AKYNZEO® 10/13/2014 7:10:19 AM
FDA Approves Eisai Inc. (ESALF.PK) Drug For Chemotherapy-Associated Nausea 10/10/2014 10:44:44 AM
Sunascen Therapeutics Gets FDA's Green Light For The New Over The Counter NAUS-EASE® Tablets 10/10/2014 8:52:25 AM
Millennium: The Takeda Oncology Company Release: FDA Approves VELCADE® (Bortezomib) For Injection For Previously Untreated Patients With Mantle Cell Lymphoma 10/9/2014 11:12:50 AM
Novartis AG (NVS) Release: (Pr)Lucentis® (ranibizumab) Approved By Health Canada To Treat Vision Loss Resulting From Choroidal Neovascularization In Pathologic Myopia (mCNV)(1) 10/8/2014 7:50:42 AM
Salix Pharmaceuticals, Ltd. (SLXP) Release: FDA Approves UCERIS® (Budesonide) 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate Distal Ulcerative Colitis 10/8/2014 11:09:50 AM
Regeneron Pharmaceuticals, Inc. (REGN) Release: EYLEA® (aflibercept) Injection Receives FDA Approval For Macular Edema Following Retinal Vein Occlusion (RVO) 10/7/2014 7:50:47 AM
1234567
//-->